Transcriptomics: Open Access
Open Access

Gene Expression Profiling: Emerging Perspectives in Molecular and Clinical Research

Camila Verhoeven^{* *}Correspondence: Camila Verhoeven, Department of Molecular Systems Biology, Leiden Institute of Biomedical Sciences, Leiden, Netherlands, Email:

Author info »

Description

Gene expression profiling has become one of the most influential technologies in modern molecular biology and biomedical science. By enabling the simultaneous analysis of thousands of genes within a cell or tissue, gene expression profiling provides detailed insight into cellular behavior, physiological adaptation, and disease progression. Early gene expression studies relied on low-throughput techniques such as Northern blotting and polymerase chain reaction methods that examined only a limited number of genes at a time. The introduction of Deoxyribonucleic Acid (DNA) microarrays marked a major advancement by allowing simultaneous measurement of thousands of transcripts. Ribonucleic Acid (RNA) sequencing technologies have largely replaced microarrays because of their greater sensitivity, broader dynamic range, and ability to identify novel transcripts and alternative splicing events. RNA sequencing has revolutionized transcriptomics by providing highly accurate and comprehensive analysis of gene expression patterns across diverse biological systems. One of its most significant applications is in cancer biology, where abnormal gene expression patterns are closely associated with tumor initiation, progression, and metastasis. Different cancers often display distinct molecular signatures that cannot be identified solely through traditional histopathological methods. Expression profiling allows researchers and clinicians to classify tumors based on molecular characteristics, improving diagnostic precision and therapeutic decision-making.

In addition to cancer research, gene expression profiling has contributed substantially to the understanding of infectious diseases. During infection, both pathogens and host cells undergo major transcriptional changes that influence disease outcomes. During recent viral outbreaks, transcriptomic studies played an important role in understanding inflammatory responses, immune dysregulation, and disease severity. These findings demonstrate the value of expression profiling in infectious disease surveillance and therapeutic development. Neurological and psychiatric disorders also involve complex alterations in gene regulation. Brain tissues exhibit highly specialized and dynamic expression patterns that influence neuronal communication, memory formation, and cognitive function. Gene expression profiling has identified transcriptional abnormalities associated with disorders such as Alzheimer’s disease, Parkinson’s disease, autism spectrum disorders, schizophrenia, and depression. Gene expression profiling also has significant applications in pharmacology and drug development. Pharmaceutical researchers use transcriptomic analyses to evaluate drug mechanisms, identify toxicological responses, and predict therapeutic efficacy. Changes in gene expression patterns following drug exposure provide valuable information about molecular pathways affected by treatment. Such approaches may improve drug safety assessments and support the development of therapies tailored to individual molecular profiles. Expression-based pharmacogenomics is becoming increasingly important in precision medicine initiatives.

Biological variability, sample quality, sequencing depth, and technical artifacts can influence the accuracy and reproducibility of transcriptomic analyses. Standardization of experimental protocols and data processing methods remains essential for ensuring reliable comparisons between studies. Integrating transcriptomics with proteomics, metabolomics, and Epigenomics therefore provides a more comprehensive understanding of biological systems. Protecting patient confidentiality and ensuring responsible use of molecular data are therefore critical components of modern biomedical research. Regulatory frameworks and ethical guidelines will continue to evolve as transcriptomic technologies become more integrated into healthcare systems. The rapid advancement of single-cell transcriptomics has further transformed gene expression profiling by enabling the analysis of gene expression at the resolution of individual cells. Conventional bulk RNA sequencing measures average gene expression across heterogeneous cell populations, potentially masking important differences among distinct cell types. Spatial transcriptomics represents another significant advancement in the field by combining gene expression profiling with spatial information within intact tissues. Unlike conventional RNA sequencing, which requires tissue dissociation, spatial transcriptomic technologies preserve the anatomical context of gene expression. The generation of transcriptomic data has outpaced the development of standardized analytical pipelines, leading to variability in data processing, normalization, and interpretation across studies. Batch effects, sequencing biases, incomplete genome annotations, and the high dimensionality of transcriptomic datasets continue to complicate biological interpretation.

References

1. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270(5235):467-470.

   [Crossref] [Google Scholar] [PubMed]

2. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 1996;14(13):1675-680.

   [Crossref] [Google Scholar] [PubMed]

3. Wang Z, Gerstein M, Snyder M. RNA-Seq: A revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10(1):57-63.

   [Crossref] [Google Scholar] [PubMed]

4. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008;5(7):621-628.

   [Crossref] [Google Scholar] [PubMed]

5. Conesa A, Madrigal P, Tarazona S, Gomez-Cabrero D, Cervera A, McPherson A, et al. A survey of best practices for RNA-seq data analysis. Genome Biol. 2016;17(1):13.

   [Crossref] [Google Scholar] [PubMed]

6. Rapaport F, Khanin R, Liang Y, Pirun M, Krek A, Zumbo P, et al. Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data. Genome Biol. 2013;14(9):3158.

   [Crossref] [Google Scholar] [PubMed]

7. Bullard JH, Purdom E, Hansen KD, Dudoit S. Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments. BMC Bioinformatics. 2010;11(1):94.

   [Crossref] [Google Scholar] [PubMed]

8. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 2012;7(3):562-578.

   [Crossref] [Google Scholar] [PubMed]

9. Liu Y, Beyer A, Aebersold R. On the dependency of cellular protein levels on mRNA abundance. Cell. 2016;165(3):535-550.

   [Crossref] [Google Scholar] [PubMed]

10. Coumailleau P, Billoud B, Sourrouille P, Moreau N, Angelier N. Evidence for a 90 kDa heat-shock protein gene expression in the amphibian oocyte. Dev Biol. 1995;168(2):247-258.

    [Crossref] [Google Scholar] [PubMed]